Search

About a third of patients with metastatic breast cancer don’t respond well to the standard anti-estrogen therapies; to find ways to better treat those patients, Memorial Sloan Kettering Cancer Center is studying three new selective estrogen receptor down-regulators (SERDs) in clinical trials.

… Thursday, June 23, 2016 While breast cancer is the most common cancer occurring in women worldwide, it is no longer considered to be a single disease. The presence or absence of an estrogen receptor, a progesterone receptor, and a protein called HER2 distinguish the subtypes of invasive breast cancer

MSK researchers continued to make strides against cancer in 2024. Learn about some of their top discoveries.

… Tuesday, December 17, 2024 Researchers at Memorial Sloan Kettering Cancer Center (MSK) continued to make strides against cancer in 2024. Laboratory research teams across the institution worked to advance the global understanding of cancer and to develop new therapies, while also making fundamental insights

Cody Bass was diagnosed with metastatic kidney cancer when he was 17. Two years later, he has no evidence of disease, thanks to a clinical trial at MSK.

… Thursday, September 5, 2024 For most teenagers, the summer before their senior year of high school is a time to hang out with friends, work a part-time job, and start thinking about college applications. But Cody Bass spent that summer recovering from a major operation at Memorial Sloan Kettering Cancer

MSK researchers have discovered a new mechanism of resistance to KRAS inhibitors that suggests an opportunity to make the treatment more effective.

… Thursday, July 11, 2024 Mutations in the KRAS gene are the primary driver of  pancreatic cancer . A new class of drugs known as KRAS inhibitors is showing initial promise in clinical trials, but many tumors quickly develop resistance to the treatment. Now, researchers at Memorial Sloan Kettering Cancer

A Black community leader seeks prompt treatment for prostate cancer, avoiding the harsh toll the disease often takes on men like him.

… Thursday, November 2, 2023 Prostate cancer takes a severe toll on Black men.   Prompt diagnosis and treatment is especially important for good outcomes. Larry Scott Blackmon was stunned when actor Chadwick Boseman passed away from colon cancer in August 2020. Several months later, Larry’s annual checkup

New results from a clinical trial led by Memorial Sloan Kettering Cancer Center (MSK), gastrointestinal oncologists Andrea Cercek, MD, and Luis Diaz Jr., MD, demonstrates how immunotherapy alone can allow people with MMRd cancers to avoid surgery and preserve their quality of life.

… Sunday, April 27, 2025 CHICAGO —   New results from a clinical trial led by Memorial Sloan Kettering Cancer Center (MSK), gastrointestinal oncologists  Andrea Cercek, MD , and  Luis Diaz Jr., MD, demonstrate how immunotherapy alone can allow people with  MMRd cancers to avoid surgery and preserve their

Women want to understand and decrease their risk of breast cancer, and Nicole Saphier, MD, Director of Breast Imaging at MSK Monmouth, wants to ensure that women make the right decisions when it comes to their breast health this October, in honor of Breast Cancer Awareness Month, and every day.

… Tuesday, October 23, 2018 Women want to understand and decrease their risk of  breast cancer ,  and Nicole Saphier, MD , Director of Breast Imaging at  MSK Monmouth , wants to ensure that women make the right decisions when it comes to their breast health this October, in honor of Breast Cancer Awareness

Total neoadjuvant therapy is a viable treatment strategy for patients with locally advanced rectal cancer and is associated with the potential to sidestep surgical treatment.

… Monday, September 10, 2018 Total neoadjuvant therapy is a viable treatment strategy for patients with locally advanced rectal cancer and is associated with improved delivery of planned therapy, increased downstaging, earlier introduction of optimal systemic chemotherapy to address micrometastases, and

Physician-scientist Michael S. Glickman specializes in the treatment and study of infectious diseases.

… Wednesday, October 1, 2008 Summary Physician-scientist Michael S. Glickman specializes in the treatment and study of infectious diseases. Physician-scientist Michael S. Glickman specializes in the treatment and study of infectious diseases. In the clinic he cares for cancer patients with a wide variety

MSK-ACCESS, a blood test that can detect mutations in 129 genes related to cancer, has already helped guide the treatment of more than 2,800 patients at MSK.

… Thursday, July 1, 2021 One of the most exciting recent developments in cancer care has been the increased use of liquid biopsies to analyze tumors. These tests, which are noninvasive and only require blood for testing, enable doctors to determine the genetic mutations driving the growth of a patient’